US-based health care firm Abbott (NYSE: ABT) this week entered into a partnership with the Department of Health – Abu Dhabi (DoH) to localize pharmaceutical production and advance digital health solutions in Abu Dhabi.
Strategic Collaboration
The partnership establishes a comprehensive plan focusing on four key pillars: localization of Abbott’s pharmaceutical portfolio, development of biosimilars, digital transformation through electronic patient information leaflets, and a robust education and workforce development program.-Fineline Info & Tech
